| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.099 | 0.6 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |